Polatuzumab Vedotin: Honing in on Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Shingleton, Jennifer R
Polatuzumab Vedotin: Honing in on Relapsed or Refractory Diffuse Large B-Cell Lymphoma. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 01 2020 - 166-168 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment
1527-7755
10.1200/JCO.19.02587 doi
Antibodies, Monoclonal
Humans
Immunoconjugates
Lymphoma, Large B-Cell, Diffuse
Polatuzumab Vedotin: Honing in on Relapsed or Refractory Diffuse Large B-Cell Lymphoma. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 01 2020 - 166-168 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment
1527-7755
10.1200/JCO.19.02587 doi
Antibodies, Monoclonal
Humans
Immunoconjugates
Lymphoma, Large B-Cell, Diffuse